Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.

Geisen, K; Hitzel, V; Okomonopoulos, R; Pünter, J; Weyer, R; Summ, H D

Geisen, K; Hitzel, V; Okomonopoulos, R; Pünter, J; Weyer, R; Summ, H D.

Arzneimittelforschung ; 35(4): 707-12, 1985.

Article in En | MEDLINE | ID: mdl-3925960

Subject(s)

Glyburide/metabolism; Hypoglycemic Agents/pharmacology; Receptors, Drug/metabolism; Sulfonylurea Compounds/metabolism; Animals; Binding, Competitive/drug effects; Blood Glucose/metabolism; Cerebral Cortex/metabolism; Female; Insulinoma/metabolism; Male; Membranes/metabolism; Neoplasm Transplantation; Pancreatic Neoplasms/metabolism; Rabbits; Rats; Rats, Inbred Strains

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Drug / Sulfonylurea Compounds / Glyburide / Hypoglycemic Agents Limits: Animals Language: En Journal: Arzneimittelforschung Year: 1985 Document type: Article Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links